InicioPodcastsThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug Company20 de noviembre de 2025 · 1 h 13 minReproducir episodioCompartir desde este puntoNotas del episodioNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.Todos los episodios de The Long Run with Luke Timmerman